molecules-logo

Journal Browser

Journal Browser

Modified Oligonucleotides: Design, Synthesis and Application

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Macromolecular Chemistry".

Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 3796

Special Issue Editor


E-Mail Website
Guest Editor
1. Head of the lab, Department of Physics, Novosibirsk State University
2. Lead Researcher, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Interests: nucleic acid chemistry; design of DNA and RNA analogues; oligonucleotide synthesis; modification and conjugation; oligonucleotide therapeutics; macromolecular drug delivery; DNA nanotechnology

Special Issue Information

Dear Colleagues,

Oligonucleotides, which by virtue of their intrinsic ability to recognize specific sequences of intracellular nucleic acids, primarily RNAs, through complementary base-pairing, are able to modulate their biological functions, have become an indispensable tool not only in molecular biology research but also in modern medicine as precision instruments for molecular diagnostics and therapy. As natural oligonucleotides are susceptible to enzymatic digestion when introduced into a living organism, the need for their stabilization through chemical modification is understood very early in their history. The first ever chemical modification—the phosphorothioate group that replaces one of the non-bridging oxygens of the phosphate group with sulfur—gave rise to the first generation of modified oligonucleotides that found application as enzymatically resistant phosphate mimetics and first oligonucleotide therapeutics. This has been followed by a plethora of other modifications: methyl phosphonates, 2’-O-alkyl RNAs, and bridged/locked nucleic acids (B/LNAs) to name just a few, involving every structural element of nucleic acids: nucleobase, sugar, and phosphate group or, sometimes, replacing all of these (save for nucleobases) with a non-natural framework such as peptide nucleic acids (PNAs) or phosphorodiamidate morpholino oligonucleotides (PMOs). One could argue that the golden age of exploring vast chemical modification space passed at the beginning of this millennium. Nevertheless, the two first decades of the 21st century have so far witnessed some particularly interesting developments in this field associated, in particular, with the discoveries of RNA interference (RNAi) and CRISPR/Cas9 genome editing, both now celebrated with Nobel prizes (2005 and 2020).

This Special Issue is aimed at providing a snapshot of contemporary modified oligonucleotide synthesis and applications, commemorating the 40th anniversary of the seminal paper by Beaucage and Caruthers that heralded the advent of the phosphoramidite chemistry (Tet. Let. 1981, 22, 1859–1862, doi:10.1016/S0040-4039(01)90461-7).

Dr. Dmitry A. Stetsenko
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • DNA and RNA analogues
  • phosphate group mimics
  • sugar-modified oligonucleotides
  • base modifications

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 3541 KiB  
Article
Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach
by Elena Marchesi, Matteo Bovolenta, Lorenzo Preti, Massimo L. Capobianco, Kamel Mamchaoui, Monica Bertoldo and Daniela Perrone
Molecules 2021, 26(24), 7662; https://doi.org/10.3390/molecules26247662 - 17 Dec 2021
Cited by 3 | Viewed by 3198
Abstract
Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′-end with ursodeoxycholic [...] Read more.
Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′-end with ursodeoxycholic acid (UDCA) involved in the targeting of human DMD exon 51, by exploiting both a pre-synthetic and a solution phase approach. The two approaches have been compared. Both strategies successfully provided the desired ASO 51 3′-UDC in good yield and purity. It should be pointed out that the pre-synthetic approach insured better yields and proved to be more cost-effective. The exon skipping efficiency of the conjugated oligonucleotide was evaluated in myogenic cell lines and compared to that of unconjugated one: a better performance was determined for ASO 51 3′-UDC with an average 9.5-fold increase with respect to ASO 51. Full article
(This article belongs to the Special Issue Modified Oligonucleotides: Design, Synthesis and Application)
Show Figures

Graphical abstract

Back to TopTop